Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Curr Protoc Hum Genet ; 86: 17.19.1-17.19.10, 2015 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-26132002

RESUMO

Hypoxanthine-guanine phosphoribosyl-transferase (HPRT) deficiency is the cause of Lesch-Nyhan disease. Adenine phosphoribosyl-transferase (APRT) deficiency causes renal calculi. The activity of each enzyme is readily determined on spots of whole blood on filter paper. This unit describes a method for detecting deficiencies of HPRT and APRT.


Assuntos
Adenina Fosforribosiltransferase/sangue , Ensaios Enzimáticos/métodos , Hipoxantina Fosforribosiltransferase/sangue , Síndrome de Lesch-Nyhan/sangue , Síndrome de Lesch-Nyhan/diagnóstico , Ensaios Enzimáticos/normas , Humanos , Controle de Qualidade
2.
Arch Neurol ; 67(6): 761-4, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20558399

RESUMO

BACKGROUND: Lesch-Nyhan disease is an inborn error of purine metabolism that results from deficiency of the activity of hypoxanthine phosphoribosyltransferase (HPRT). The heterogeneity of clinical phenotypes seen in HPRT deficiency corresponds to an inverse relationship between HPRT enzyme activity and clinical severity. With rare exception, each mutation produces a stereotypical pattern of clinical disease; onset of neurologic symptoms occurs during infancy and is thought to be nonprogressive. OBJECTIVE: To document a family in which a single HPRT gene mutation has led to 3 different clinical and enzymatic phenotypes. DESIGN: Case report. Settings A university-based outpatient metabolic clinic and a biochemical genetics laboratory. Patients Three males (2 infants and their grandfather) from the same family with Lesch-Nyhan variant, including one of the oldest patients with Lesch-Nyhan variant at diagnosis (65 years). MAIN OUTCOME MEASURES: Clinical and biochemical observations. RESULTS: Sequencing of 5 family members revealed a novel mutation c.550G>T in exon 7 of the HPRT gene. The considerably variable clinical phenotype corresponded with the variable enzymatic activity in the 3 males, with the grandfather being the most severely affected. CONCLUSIONS: The different phenotypes encountered in the enzymatic analysis of cultured fibroblasts from a single mutation in the same family is unprecedented. The significant decrease in the grandfather's HPRT enzymatic activity compared with that of his grandchildren could be a function of the Hayflick Limit Theory of cell senescence.


Assuntos
Saúde da Família , Hipoxantina Fosforribosiltransferase/genética , Síndrome de Lesch-Nyhan/genética , Síndrome de Lesch-Nyhan/fisiopatologia , Mutação/genética , Idoso , Pré-Escolar , Análise Mutacional de DNA , Feminino , Humanos , Hipoxantina Fosforribosiltransferase/metabolismo , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA